Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)
PHASE3CompletedINTERVENTIONAL
Enrollment
372
Participants
Timeline
Start Date
May 31, 2003
Primary Completion Date
June 30, 2004
Study Completion Date
June 30, 2004
Conditions
HypercholesterolemiaCoronary Disease
Interventions
DRUG
MK0653, ezetimibe
DRUG
Comparator: ezetimibe, placebo
All Listed Sponsors
lead
Organon and Co
INDUSTRY
NCT00092612 - Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED) | Biotech Hunter | Biotech Hunter